Your browser doesn't support javascript.
loading
Comparison of gene expression patterns across 12 tumor types identifies a cancer supercluster characterized by TP53 mutations and cell cycle defects.
Martínez, E; Yoshihara, K; Kim, H; Mills, G M; Treviño, V; Verhaak, R G W.
Afiliação
  • Martínez E; 1] Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA [2] Catedra de Bioinformatica, Tecnologico de Monterrey, Monterrey, Nuevo Leon, Mexico.
  • Yoshihara K; 1] Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA [2] Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Niigata, Japan.
  • Kim H; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Mills GM; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Treviño V; Catedra de Bioinformatica, Tecnologico de Monterrey, Monterrey, Nuevo Leon, Mexico.
  • Verhaak RG; 1] Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA [2] Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Oncogene ; 34(21): 2732-40, 2015 May 21.
Article em En | MEDLINE | ID: mdl-25088195
ABSTRACT
Transcriptional profile-based subtypes of cancer are often viewed as identifying different diseases from the same tissue origin. Understanding the mechanisms driving the subtypes may be key in development of novel therapeutics but is challenged by lineage-specific expression signals. Using a t-test statistics approach, we compared gene expression subtypes across 12 tumor types, which identified eight transcriptional superclusters characterized by commonly activated disease pathways and similarities in gene expression. One of the largest superclusters was determined by the upregulation of a proliferation signature, significant enrichment in TP53 mutations, genomic loss of CDKN2A (p16(ARF)), evidence of increased numbers of DNA double strand breaks and high expression of cyclin B1 protein. These correlations suggested that abrogation of the P53-mediated apoptosis response to DNA damage results in activation of cell cycle pathways and represents a common theme in cancer. A second consistent pattern, observed in 9 of 11 solid tumor types, was a subtype related to an activated tumor-associated stroma. The similarity in transcriptional footprints across cancers suggested that tumor subtypes are commonly unified by a limited number of molecular themes.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Expressão Gênica / Ciclo Celular / Genes p53 / Proteína Supressora de Tumor p53 / Mutação / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Expressão Gênica / Ciclo Celular / Genes p53 / Proteína Supressora de Tumor p53 / Mutação / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article